XM无法为美国居民提供服务。

Guardian Pharmacy targets up to $974 mln valuation in US IPO



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 2-Guardian Pharmacy targets up to $974 mln valuation in US IPO</title></head><body>

Adds background and details on results in paragraphs 4-11

Sept 16 (Reuters) -Guardian Pharmacy Services said on Monday it was targeting a valuation as much as $973.5 million in its initial public offering in the United States.

Expectations of an imminent interest rate cut by the U.S. Federal Reserve are encouraging more companies to press ahead with their listing plans.

Guardian Pharmacy is aiming to raise as much as $108 million by offering 6.75 million shares at a price range of $14 to $16 each.

Founded in 2004, the Atlanta-based company provides pharmacy services to long-term health care facilities in the United States. It owns 50 pharmacies and serves 174,000 residents across 36 states.

The company counts pharmacy services providers Omnicare, PharMerica, PharmCareUSA and Polaris Pharmacy Services among its competitors.

Guardian Pharmacy's revenue jumped to $575.4 million in the six months ended June 30, compared with $502.4 million in the same period in 2023.

More than two-thirds of Guardian Pharmacy's annual revenue over the past three years was from residents of assisted living facilities and behavioral health facilities and group homes, the company said.

The company earned $22.9 million in the first half of this year, compared with $30.2 million in the same period in 2023.

Guardian Pharmacy counts investment firms Bindley Capital Partners and Cardinal Equity Partners among its backers.

William Bindley serves as the chairman of Guardian Pharmacy. He was the founder and CEO of pharmaceutical distribution firm Bindley Western, which was acquired by Cardinal Health CAH.N in a $2.1 billion deal in 2001.

Guardian Pharmacy, which will use a portion of the IPO proceeds to lower debt, plans to list on the New York Stock Exchange under the symbol "GRDN".

Raymond James, Truist Securities and Stephens Inc are the underwriters for the offering.



Reporting by Arasu Kannagi Basil in Bengaluru; Editing by Shounak Dasgupta

</body></html>

免责声明: XM Group仅提供在线交易平台的执行服务和访问权限,并允许个人查看和/或使用网站或网站所提供的内容,但无意进行任何更改或扩展,也不会更改或扩展其服务和访问权限。所有访问和使用权限,将受下列条款与条例约束:(i) 条款与条例;(ii) 风险提示;以及(iii) 完整免责声明。请注意,网站所提供的所有讯息,仅限一般资讯用途。此外,XM所有在线交易平台的内容并不构成,也不能被用于任何未经授权的金融市场交易邀约和/或邀请。金融市场交易对于您的投资资本含有重大风险。

所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。

本网站上由XM和第三方供应商所提供的所有内容,包括意见、新闻、研究、分析、价格、其他资讯和第三方网站链接,皆保持不变,并作为一般市场评论所提供,而非投资性建议。所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为适用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。请确保您已阅读并完全理解,XM非独立投资研究提示和风险提示相关资讯,更多详情请点击 这里

风险提示: 您的资金存在风险。杠杆商品并不适合所有客户。请详细阅读我们的风险声明